What is the procedure for the 4-glass test (Meares-Stamey test) for chronic bacterial prostatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Meares-Stamey 4-Glass Test Procedure for Chronic Bacterial Prostatitis

The Meares-Stamey 4-glass test involves sequential collection of four specimens: first-void urine (VB1), midstream urine (VB2), expressed prostatic secretions (EPS) via prostatic massage, and post-massage urine (VB3), with a positive result defined as a 10-fold higher bacterial count in the EPS compared to midstream urine. 1, 2

Step-by-Step Collection Protocol

Specimen Collection Sequence

  • VB1 (First-void urine): Collect the initial 5-10 mL of voided urine to sample the urethra 3, 4

  • VB2 (Midstream urine): Collect midstream urine (approximately 10-20 mL) to sample the bladder 1, 3

  • EPS (Expressed prostatic secretions): Perform digital rectal examination with prostatic massage to express prostatic fluid, collecting any secretions that appear at the urethral meatus 1, 3

  • VB3 (Post-massage urine): Immediately after prostatic massage, collect the first 5-10 mL of voided urine to capture prostatic secretions that drained into the urethra 1, 4

Laboratory Processing Requirements

  • Transport time: All specimens must reach the laboratory within 1 hour in closed sterile containers, or be refrigerated at 4°C if transport is delayed 1

  • Diagnostic procedures: Perform both Gram stain or cell counts to identify inflammatory cells, and aerobic culture to identify pathogens 1, 3

  • Quantitative culture: Bacterial colony counts must be quantified for each specimen to allow comparison 1, 5

Interpretation Criteria

A positive test requires a 10-fold (or greater) higher bacterial count in the EPS compared to the VB2 (midstream urine) specimen. 1, 2, 3

  • The most common pathogens are Gram-negative organisms including E. coli (approximately 50% of cases), followed by Enterococcus species (approximately 32%), Proteus mirabilis, Enterobacter species, and Serratia marcescens 3, 6

  • White blood cell counts should also be compared, with the optimal cutpoint being ≥3 WBCs in VB3 to predict ≥5 WBCs in EPS (76% sensitivity, 70% specificity) 4

Simplified 2-Glass Alternative

When EPS cannot be obtained (which occurs in >50% of attempts), the 2-glass test using only VB2 (midstream urine) and VB3 (post-massage urine) is an acceptable alternative with >96% concordance to the 4-glass test. 2, 3, 4

  • The 2-glass test has 44-54% sensitivity but 100% specificity for detecting uropathogens when compared to the full 4-glass test 4

  • VB3 white blood cell count ≥4 predicts ≥10 WBCs in EPS with 62% sensitivity and 75% specificity 4

Critical Contraindications and Pitfalls

  • Never perform prostatic massage in acute bacterial prostatitis due to high risk of bacteremia—this is a strong contraindication 2, 3

  • Failure to obtain EPS occurs in less than 50% of patients in routine practice, making the test non-diagnostic unless the 2-glass variant is used 7

  • The diagnostic yield improves significantly (from 31% to 64%) when performed by dedicated staff experienced in prostatitis evaluation rather than general urologists 6

  • Patient selection matters: the test has 81% positivity in patients with prostatitis symptoms only, versus only 29-34% in patients with mixed or BPH-only symptoms 6

  • Semen culture alone should not be used for diagnosis as it cannot differentiate prostatic infection from urethral or seminal vesicle contamination 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach to Prostatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosing Chronic Prostatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.